Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Phase I-II Study Using Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Brief Summary: This trial designed to evaluate the toxicity and efficacy of tocilizumab in the treatment of steroid refractory acute Graft versus host disease (GVHD).